Cite
HARVARD Citation
Cloughesy, T. et al. (2018). Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Neuro-oncology. 20 (2), pp. 259-267. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cloughesy, T. et al. (2018). Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Neuro-oncology. 20 (2), pp. 259-267. [Online].